Compare Abbott India with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs SUN PHARMA - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA SUN PHARMA ABBOTT INDIA/
SUN PHARMA
 
P/E (TTM) x 52.7 86.1 61.2% View Chart
P/BV x 17.0 3.7 463.5% View Chart
Dividend Yield % 0.4 0.6 69.8%  

Financials

 ABBOTT INDIA   SUN PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
SUN PHARMA
Mar-20
ABBOTT INDIA/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs8,834484 1,824.9%   
Low Rs5,458315 1,731.4%   
Sales per share (Unadj.) Rs1,731.1136.9 1,264.8%  
Earnings per share (Unadj.) Rs211.917.5 1,214.4%  
Cash flow per share (Unadj.) Rs219.926.0 845.5%  
Dividends per share (Unadj.) Rs65.004.00 1,625.0%  
Dividend yield (eoy) %0.91.0 90.9%  
Book value per share (Unadj.) Rs945.2188.7 501.0%  
Shares outstanding (eoy) m21.252,399.26 0.9%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x4.12.9 141.4%   
Avg P/E ratio x33.722.9 147.2%  
P/CF ratio (eoy) x32.515.4 211.5%  
Price / Book Value ratio x7.62.1 356.9%  
Dividend payout %30.722.9 133.8%   
Avg Mkt Cap Rs m151,848958,864 15.8%   
No. of employees `0003.517.8 19.6%   
Total wages/salary Rs m4,35663,624 6.8%   
Avg. sales/employee Rs Th10,555.518,490.6 57.1%   
Avg. wages/employee Rs Th1,249.93,582.6 34.9%   
Avg. net profit/employee Rs Th1,292.22,357.6 54.8%   
INCOME DATA
Net Sales Rs m36,786328,375 11.2%  
Other income Rs m1,1336,360 17.8%   
Total revenues Rs m37,919334,735 11.3%   
Gross profit Rs m6,04769,898 8.7%  
Depreciation Rs m16920,528 0.8%   
Interest Rs m233,027 0.7%   
Profit before tax Rs m6,98952,702 13.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-2,606 0.0%   
Tax Rs m2,4858,228 30.2%   
Profit after tax Rs m4,50341,868 10.8%  
Gross profit margin %16.421.3 77.2%  
Effective tax rate %35.615.6 227.8%   
Net profit margin %12.212.8 96.0%  
BALANCE SHEET DATA
Current assets Rs m27,610316,542 8.7%   
Current liabilities Rs m8,569157,064 5.5%   
Net working cap to sales %51.848.6 106.6%  
Current ratio x3.22.0 159.9%  
Inventory Days Days6088 68.8%  
Debtors Days Days27105 26.2%  
Net fixed assets Rs m1,057243,102 0.4%   
Share capital Rs m2132,399 8.9%   
"Free" reserves Rs m19,873450,245 4.4%   
Net worth Rs m20,086452,645 4.4%   
Long term debt Rs m020,289 0.0%   
Total assets Rs m29,409682,525 4.3%  
Interest coverage x311.618.4 1,692.6%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.30.5 260.0%   
Return on assets %15.46.6 234.0%  
Return on equity %22.49.2 242.4%  
Return on capital %34.911.2 310.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m36974,219 0.5%   
Fx outflow Rs m4,91827,964 17.6%   
Net fx Rs m-4,54946,255 -9.8%   
CASH FLOW
From Operations Rs m4,99165,548 7.6%  
From Investments Rs m-2,570-25,888 9.9%  
From Financial Activity Rs m-1,428-57,151 2.5%  
Net Cashflow Rs m993-13,857 -7.2%  

Share Holding

Indian Promoters % 0.0 63.7 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 5.1 154.0%  
FIIs % 0.1 23.0 0.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 8.3 206.0%  
Shareholders   18,270 133,026 13.7%  
Pledged promoter(s) holding % 0.0 0.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   IPCA LABS  SANOFI INDIA  DR. DATSONS LABS  PROCTER & GAMBLE HEALTH  NOVARTIS  

Compare ABBOTT INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty End Flat; Asian Paints, UPL & ITC Among Top Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (3QFY21); Net Profit Down 5.1% (Quarterly Result Update)

Feb 11, 2021 | Updated on Feb 11, 2021

For the quarter ended December 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (down 5.1% YoY). Sales on the other hand came in at Rs 11 bn (up 1.6% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 87.4% YoY). Sales on the other hand came in at Rs 88 bn (up 8.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2019-20 Annual Report Analysis (Annual Result Update)

Dec 11, 2020 | Updated on Dec 11, 2020

Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 66.9% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 66.9% YoY). Sales on the other hand came in at Rs 86 bn (up 5.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY21); Net Profit Up 54.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

Is Intraday Trading For You?(Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution(Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


May 14, 2021 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 5-YR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS